PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320178
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320178
Heart-Lung Machine Market size was valued at USD 380.9 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.
A heart-lung machine is a piece of equipment that temporarily takes over the work of the heart and/or lungs, providing blood and oxygen to the body. A heart-lung machine may also be used on a person who needs heart or respiratory support for non-surgical reasons. For example, the machine can be used for someone with heart failure who is waiting for a heart transplant. The heart-lung machine is essential in open-heart surgery and other cardiac procedures in which the heart must be halted or its function must be bypassed. It is most commonly utilized in coronary artery bypass grafting (CABG), heart valve repair or replacement, and heart transplantation.
As the world's population ages, the prevalence of cardiovascular disorders rises, resulting in a greater demand for cardiac surgery. Heart-lung machines are frequently used to support patients undergoing difficult procedures such as coronary artery bypass grafting (CABG), heart valve repair or replacement, and a heart transplant. According to Lifespan Health System, Heart disease is the leading cause of death for men and women in the United States. Today, there are about 500,000 open heart surgeries performed each year. The increasing healthcare expenditure in many countries allows for better access to advanced medical technologies, including heart-lung machines can provide growth opportunities for the market. However, the complex and expensive medical devices hamper the market growth.
The Global Heart-Lung Machine Market is segmented on the basis of Product Type, Application, End-User, and Region.
The market is divided into three categories based on product type: Single Roller Pump and Double Roller Pump. Single Roller Pump dominates the market. Due to its simplicity, accuracy, and convenience of use, the single roller pump is a reliable and commonly used pumping mechanism in heart-lung machines.
The market is divided into two categories based on application: Coronary Artery Bypass Grafting (CABG), Heart Valve Surgeries, Heart Transplants, Lung Transplants, and Others. Coronary Artery Bypass Grafting (CABG) is expected to dominate the market. Coronary Artery Bypass Grafting (CABG) is a surgical treatment used to treat coronary artery disease (CAD), which develops when the coronary arteries that feed blood to the heart muscle become blocked or narrowed.
The market is divided into two categories based on End-User: Hospitals, Cardiac Centers, and Others. The Hospitals sector dominates the market and is likely to maintain its dominance during the forecast period. Heart-lung machines, also known as cardiopulmonary bypass (CPB) machines, are vital in hospitals during cardiac surgeries, especially those involving open-heart procedures such as coronary artery bypass grafting (CABG) and heart valve surgery.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Heart-Lung Machine Market, due to the number of geriatric population suffering from various heart-related disorders. The aging population in North America, notably in the United States and Canada, is huge and expanding. The chance of acquiring heart-related illnesses such as coronary artery disease, valvular heart disease, and heart failure increases considerably with age. The older population reached 55.8 million or 16.8% of the population of the United States in 2020, according to the U.S. Department of Commerce. Europe is the second largest market for Heart-Lung machines, due to Advanced Healthcare Infrastructure.
A few well-established companies dominate the production and distribution of heart-lung machines. In the medical device market, these companies compete to deliver innovative and dependable heart-lung machines that match the strict standards of cardiac procedures. Product features, technological improvements, regulatory compliance, customer service, and pricing all have an effect on the competitive environment in this industry. For Example, Hemovent GmbH announced nowadays that it won CE Mark approval for its Mobybox Runner controller for heart and lung support.
6 May 2023, Recently, Hemovent announced that its Extracorporeal Life Support (ECLS) product, the MOBYBOX system, completed the EU Medical Device Regulation (MDR) certification process. In 2019, MOBYBOX was awarded the CE mark under the European Medical Device Directive (MDD). The MDR establishes a more stringent regulatory system for medical devices compared to MDD.
The scope of this report covers the market by its major segments, which include as follows: